Masitinib API
Small-Molecule Active Pharmaceutical Ingredient for Human Drug Development
Material Overview
Masitinib is supplied as a small-molecule active pharmaceutical ingredient (API) intended for human drug development and formulation work. It is delivered as a crystalline powder with documented purity and analytical results, suitable for preclinical formulation studies, analytical method development, and early-stage manufacturing trials.
This page focuses on material characteristics relevant to technical evaluation, quality control, and supply planning - not on clinical or therapeutic claims.
Fundamental Specifications
- ▸ CAS Number: 790299-79-5
- ▸ Material Form: White to off-white crystalline solid
- ▸ Purity / Assay: ≥ 98% (HPLC), lot-validated
- ▸ Chemical Class: Small-molecule kinase inhibitor intermediate
- ▸ Solubility: Soluble in selected organic solvents (see technical sheet)
Storage Guidance
- ▸ Store sealed, dry, and protected from moisture and light
- ▸ Short-term: 2–8 °C
- ▸ Long-term: −20 °C recommended
- ▸ Documentation: COA, MSDS/TDS, impurity & stability summaries
- ▸ Packaging: Sample vials, bulk supply, OEM/custom formats available
Release metrics are structured to allow rapid integration into existing QC and analytical workflows.
What Procurement & Development Teams Look For
Item Consistency
Each lot includes assay values, retention time markers, and impurity profiles to enable direct comparison against internal reference standards.
Solvent Handling Notes
Preliminary solvent compatibility data is supplied with sample shipments to support early screening formulation and scale-up planning.
Temperature & Moisture Behavior
Controlled packaging and handling instructions help preserve crystalline integrity during transit and storage.
Handling & Bench Notes
- ▸ Allow sealed containers to equilibrate to room temperature before opening
- ▸ Reseal promptly after opening to limit air exposure
- ▸ Use validated solvents and filtration protocols
- ▸ Log batch data into LIMS / ERP systems on receipt
These practices help minimize assay variability across laboratories and facilities.
Packaging, Logistics & Traceability
- ▸ Moisture-barrier primary packaging with desiccant
- ▸ Temperature-controlled shipping available
- ▸ Clear batch and lot identification
- ▸ Physical and digital documentation for audits
Procurement Pathway
1. Sample Evaluation
Confirm analytical performance and handling behavior.
2. Documentation Alignment
Review COA, impurity, and stability data.
3. Production Supply
Transition to bulk supply with agreed packaging and lead times.
This staged approach reduces risk and aligns supply with development timelines.
Frequently Asked Questions
Q: Is this a finished therapeutic product?
A: No. Masitinib is supplied as an API and must be formulated under regulatory oversight.
Q: What documentation is provided?
A: COA, MSDS/TDS, impurity summaries, and stability profiles.
Q: How should the API be stored?
A: Sealed, dry, protected from light; 2–8 °C short-term, −20 °C long-term.
Q: Are evaluation quantities available?
A: Yes. Sample orders are supported.
Q: Can packaging be customized?
A: Yes. OEM and custom labeling options are available.
Request Masitinib API Samples or Technical Documentation
Technical evaluation support and scalable supply available upon request.
Hot Tags: masitinib for human cas 790299-79-5, China masitinib for human cas 790299-79-5 manufacturers, suppliers, factory, 145108-58-3, Masitinib, Dexmedetomidine HCL, Avibactam Sodium, Avibactam, 1192491-61-4
